Michael Kaschke received his Ph.D. degree from the Friedrich Schiller University of Jena in 1986 for his research in the field of ultra-short light pulses and ultrafast spectroscopy. Before joining Carl Zeiss, he was a research scientist at Max-Born-Institute Berlin, Max-Planck-Institute G ttingen, and invited visiting scientist at IBM Research Center York- town Heights, N.Y., working on high-power fs-laser pulses and their matter interaction. He joined the Carl Zeiss Group in 1992 and has held since then several research and management positions in the company, predominantly in the medical business. Michael Kaschke is currently President and CEO of the Carl Zeiss Group, a technology leader in optics, optoelectronic, and medical tech- nology headquartered in Oberkochen, Germany. He is also a professor for medical technology at the Karlsruhe Institute of Technology, Germany.
Karl-Heinz Donnerhacke received his Ph.D. degree from the Friedrich Schiller University of Jena, Germany, in 1976 for his research in the field of high power gas lasers. He spent over 25 years of his professional career working at Carl Zeiss in laser development and laser application in medicine. Until his retirement he was Director of R&D in the Ophthalmic Diagnostic Instruments Division of Carl Zeiss/Carl Zeiss Meditec for almost 20 years. Since 2003, Karl-Heinz Donnerhacke has been an adjunct professor for ophthalmic technology at the Ernst Abbe University of Applied Sciences Jena, Germany and the Technical University Ilmenau, Germany. Currently he also works as a technology consultant in the field of ophthalmic devices.
Michael Stefan Rill received his Ph.D. degree from the Institute of Applied Physics at the Karlsruhe Institute of Technology, Germany, in 2010 for his research in the field of 3D photonic metamaterials. He joined Carl Zeiss in Oberkochen, Germany as a scientific assistant to the CEO in 2010. In 2013 Michael Stefan Rill assumed the position of product manager for cataract surgery systems at Carl Zeiss in Jena, Germany.
